Patent · US Active

Dry powder drug delivery system and methods

US9662461B2 · kind B2 · utility

6Cited by
899References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 2, 2016
Grant dateMay 30, 2017
Priority date
Expiry dateMay 2, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2205/6081
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A pulmonary drug delivery system is disclosed, including a breath-powered, dry powder inhaler, and a cartridge for delivering a dry powder formulation. The inhaler and cartridge can be provided with a drug delivery formulation comprising, for example, a diketopiperazine and an active ingredient, including, small organic molecules, peptides and proteins, including, insulin and glucagon-like peptide 1 for the treatment of disease and disorders, for example, endocrine disease such as diabetes and/or obesity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.